Efficacy and safety of long-term tildrakizumab for moderate to severe chronic plaque psoriasis: 3-year results from reSURFACE 1

被引：0

作者：

Tyring, S. ^{[1
]}

Spelman, L. ^{[2
,3
]}

Igarashi, A. ^{[4
]}

Ohtsuki, M. ^{[5
]}

Li, Q. ^{[6
]}

Mendelsohn, A. ^{[7
]}

Parno, J. ^{[7
]}

Guenthner, S. ^{[8
]}

机构：

[1] Univ Texas Houston, Dept Dermatol, UTHlth, Houston, TX USA

[2] Verac Clin Res, Brisbane, Qld, Australia

[3] Prob Med Res, Waterloo, ON, Canada

[4] NNT Med Ctr Tokyo, Tokyo, Japan

[5] Jichi Med Univ Hosp, Shimotsuke, Tochigi, Japan

[6] Merck & Co Inc, Kenilworth, NJ USA

[7] Sun Pharmaceut Ind Inc, Princeton, NJ USA

[8] Indiana Univ Sch Med, Indianapolis, IN 46202 USA

来源：

AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2019年 / 60卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：61 / 61

页数：1

共 50 条

[41] Bimekizumab Efficacy and Safety Through 4 Years in Moderate to Severe Plaque Psoriasis: Long-Term Results from a Phase 3 Study and Open-Label Extension [J].

Thaci, Diamant ;

Puig, Luis ;

Merola, Joseph F. ;

Jullien, Denis ;

Costanzo, Antonio ;

Wang, Maggie ;

Deherder, Delphine ;

Lopez Pinto, Jose M. ;

Lebwohl, Mark .

ARTHRITIS & RHEUMATOLOGY, 2024, 76 :4733-4735

[42] Long-term safety of ustekinumab in paediatric patients with moderate-to-severe plaque psoriasis: results from an ongoing observational study [J].

Mahe, Emmanuel ;

Geldhof, Anja ;

Movshovich, Evgenia ;

Schreiber, Joerg ;

Malynn, Sandra ;

Efficace, Michela ;

Seyger, Marieke M. B. .

BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (03) :E43-E43

[43] Long-term efficacy and safety of tildrakizumab in patients with moderate-to-severe psoriasis who were partial responders or nonresponders to etanercept: Post hoc analysis through 5 years from the reSURFACE 2 phase 3 trial [J].

Thaci, Diamant ;

Griffiths, Christopher E. M. ;

Iversen, Lars ;

Peserico, Andrea ;

Pau-Charles, Ignasi ;

Blauvelt, Andrew ;

Reich, Kristian .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) :AB119-AB119

[44] Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis [J].

van de Kerkhof, PCM ;

Berth-Jones, J ;

Griffiths, CEM ;

Harrison, PV ;

Hönigsmann, H ;

Marks, R ;

Roelandts, R ;

Schöpf, E ;

Trompke, C .

BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (03) :414-422

[45] Deucravacitinib Long-term Efficacy and Safety in Plaque Psoriasis: 2-Year Results from the Phase 3 POETYK PSO Program [J].

Warren, Richard ;

Sofen, Howard ;

Imafuku, Shinichi ;

Szepietowski, Jacek C. ;

Blauvelt, Andrew ;

Spelman, Lynda ;

Toms, Jessica ;

Buck, Alex ;

Banerjee, Subhashis ;

Menter, Alan .

ARTHRITIS & RHEUMATOLOGY, 2022, 74 :4230-4232

[46] Deucravacitinib long-term efficacy and safety in plaque psoriasis: 2-year results from the phase 3 POETYK PSO program [J].

Spelman, Lynda ;

Warren, Richard B. ;

Sofen, Howard ;

Imafuku, Shinichi ;

Blauvelt, Andrew ;

Toms, Jessica ;

Buck, Alex ;

Banerjee, Subhashis ;

Menter, Alan ;

Szepietowski, Jacek C. .

AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 :28-28

[47] DEUCRAVACITINIB LONG-TERM EFFICACY AND SAFETY IN PLAQUE PSORIASIS: 2-YEAR RESULTS FROM THE PHASE 3 POETYK PSO PROGRAM [J].

Warren, R. B. ;

Sofen, H. ;

Imafuku, S. ;

Szepietowski, J. ;

Blauvelt, A. ;

Spelman, L. ;

Colston, E. ;

Toms, J. ;

Buck, A. ;

Banerjee, S. ;

Menter, A. .

ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 :841-841

[48] Efficacy of long-term tildrakizumab for plaque psoriasis: PASI 50/75/90/100 and PGA for up to 5 years of treatment in reSURFACE 2 [J].

Roebuck, Heather ;

Farberg, Aaron S. ;

Hanna, Sameh ;

Mendelsohn, Alan M. ;

Rozzo, Stephen J. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) :AB80-AB80

[49] Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: Updated results from an ongoing trial [J].

Gottlieb, AB ;

Hamilton, T ;

Caro, I ;

Kwon, P ;

Compton, PG ;

Leonardi, CL .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (04) :S154-S163

[50] Tildrakizumab efficacy by metabolic syndrome status in psoriasis: Post hoc analysis of 3-year data from the phase 3 reSURFACE 2 study [J].

Gottlieb, Alice B. ;

Mehta, Nehal N. ;

Lebwohl, Mark ;

Mendelsohn, Alan M. ;

Parno, Jeff ;

Rozzo, Stephen J. ;

Menter, Alan .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) :AB164-AB164

← 1 2 3 4 5 →